Skip to main content

Table 2 Description of clinical and psychosocial factors of participants with schizophrenia spectrum disorders in Comprehensive Specialized Hospitals, Amhara region, Ethiopia, 2020 (n = 404)

From: Lifetime relapse and its associated factors among people with schizophrenia spectrum disorders who are on follow up at Comprehensive Specialized Hospitals in Amhara region, Ethiopia: a cross-sectional study

Variables Frequency (404) Percentage (%)
Clinical diagnosis
 Schizophrenia 346 85.6
 Schizophreniform 9 2.2
 Schizo-affective 26 6.4
 Delusional 16 4
 Brief psychotic 7 1.8
Age of onset
  < 20 years 44 10.9
  ≥ 20 years 360 89.1
Delayed treatment
  < 1 month 123 30.5
 1–6 months 87 21.5
  > 6 months 194 48.0
Duration on treatment
 Within 5 years 302 74.8
  > 5 years 102 25.2
Types of medication taking
 First generation APS 183 45.3
 Second generation APS 171 42.3
 Combination of first and second generation APS 2 0.5
 Others* 48 11.9
Previous suicidal ideation
 Yes 15 3.7
 No 389 96.3
Comorbid of another mental illnesses
 Yes 92 22.8
 No 312 77.2
Comorbid another medical illness
 Yes 47 11.6
 No 357 88.4
Medication adherence
 Adherent 301 74.5
 Non adherent 103 25.5
Medication side effect
 Mild side effect 237 58.7
 Moderate side effect 133 32.9
 Severe side effect 34 8.4
Social support
 Poor support 151 37.4
 Moderate support 142 35.1
 Severe support 111 27.5
Stressful event
 No stressful event 53 13.1
 1or 2 stressful events 134 33.2
  ≥ 3 stressful events 217 53.7
  1. * = Antipsychotic and antidepressants, antipsychotic and mood stabilizers; APS Antipsychotics